Results 81 to 90 of about 6,290,967 (378)

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad   +8 more
wiley   +1 more source

Index to Jack Shannahan Interview [PDF]

open access: yes, 2019
This index provides a time-stamped overview of the subjects discussed during an oral history interview with Erwin Jack Shannahan, Linfield College class of ...
Harder, Elisia
core   +1 more source

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji   +9 more
wiley   +1 more source

An Interview with Geraldine Keams [PDF]

open access: yes, 1987
When Geraldine Keams visited Iowa State University for the annual Symposium on the American Indian in 1983, I had the opportunity to interview her. The tape remained untranscribed until we met again in California during the fall of 1986, more than three ...
Bataille, Gretchen M.
core   +1 more source

Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the long‐term impact of early intensive treatment (EIT) versus escalation (ESC) strategies using high‐efficacy disease‐modifying therapies (HE‐DMTs) on disability progression in relapsing multiple sclerosis (RMS). Methods This observational study included 4878 RMS patients from the Italian Multiple Sclerosis Register ...
Pietro Iaffaldano   +47 more
wiley   +1 more source

Review: Arnd-Michael Nohl (2009). Interview und dokumentarische Methode. Anleitungen für die Forschungspraxis [Interview and Documentary Methods: Guidelines for Practical Research]

open access: yesForum: Qualitative Social Research, 2010
In his book "Interview and Documentary Methods: Guidelines for Practical Research," educationalist Arndt-Michael NOHL explains how documentary methods for the interpretation of interviews can be brought to fruition.
Johannes Twardella
doaj  

Teleradiology of Korea in 2017: Survey and Interview of Training Hospitals and Teleradiology Center

open access: yes대한영상의학회지, 2019
Purpose Teleradiology has been widely used nationwide in various ways. In order to prepare a guideline, it was recognized that a survey on the actual condition of teleradiology in Korea was necessary.
Hyunsik Woo   +10 more
doaj   +1 more source

An Interview About an Illness [PDF]

open access: yes, 2009
The respondent tells of his experience of a life-threatening illness.The fifty one audio and nine video files in this collection include: villages’ life stories, circle-dancing songs and performance, local history, folk tales, and interviews from ...
G.yu lha
core  

Comparison of web-based and face-to-face interviews for application to an anesthesiology training program: a pilot study. [PDF]

open access: yes, 2016
ObjectiveThis study compared admission rates to a United States anesthesiology residency program for applicants completing face-to-face versus web-based interviews during the admissions process.
Applegate, Richard L   +5 more
core   +2 more sources

Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Ocrelizumab (OCR), a humanized anti‐CD20 monoclonal antibody, is highly efficient in relapsing–remitting multiple sclerosis (RR‐MS). We assessed early cellular B‐cell profiles in patients prior to OCR treatment, on OCR treatment, and after 15 months of therapy discontinuation.
Alexandra Garcia   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy